Correlation between virus genotype and chronicity rate in acute hepatitis C
References (34)
Variability of hepatitis C virus
Hepatology
(1995)- et al.
Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology.
Hepatology
(1996) - et al.
Hepatitis C virus genotypes and risk of hepato-cellular carcinoma in cirrhosis: a case-control study.
Gastroenterology
(1996) - et al.
Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis.
Hepatology
(1997) - et al.
HCV genotypes in chronic hepatitis C and response to interferon.
Lancet
(1992) - et al.
the OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Natural history of liver fibrosis progression in patients with chronic hepatitis C
Lancet
(1997) - et al.
Influence of different hepatitis C virus genotypes on the course of asymtomatic hepatitis C virus infection.
Gastroenterology
(1996) - et al.
Isolation of a cDNA clone derived from a blood borne non-A, non-B hepatitis genome.
Science
(1989) - et al.
The natural history of community-acquired hepatitis C in the United States.
N Engl J Med
(1992) - et al.
Clinical outcomes after transfusion-associated hepatitis C
N Engl J Med
(1995)
Pathogenic factors in cirrhosis with and without hepatocellular carcinoma: a multicenter Italian study.
Hepatology
Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study.
Ann Intern Med
At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.
Proc Natl Acad Sci USA
The International HCV Collaborative Study Group.
J Gen Virol
Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region.
J Gen Virol
Evoluntionary analysis of variants hepatitis C virus found in South-East Asia: comparison with classification based upon sequence similarity
J Gen Virol
A proposed system for the nomenclature of hepatitis C viral genotypes.
Hepatology
Cited by (104)
Liver disease among renal transplant recipients
2019, Kidney Transplantation - Principles and PracticeProduction and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6
2014, VirologyCitation Excerpt :Due to a high degree of genetic heterogeneity, HCV has been classified into 6 epidemiologically important genotypes and numerous subtypes, differing in approximately 30% and 20% of their nucleotide and amino acid sequence, respectively (Simmonds et al., 2005; Gottwein and Bukh, 2008). Genotypes show important clinical and biological differences (Amoroso et al., 1998; Cross et al., 2010; Prentoe et al., 2011; Scheel et al., 2012; Sarrazin et al., 2012; Scheel and Rice, 2013). Serotypes have not been defined; however, different genotypes and subtypes show differential sensitivity to neutralizing antibodies found in sera of chronically infected patients and to monoclonal neutralizing antibodies with therapeutic potential (Meunier et al., 2005; Jensen et al., 2008; Gottwein et al., 2009; Prentoe et al., 2011; Giang et al., 2012).
Phylogeny and molecular evolution of the hepatitis C virus
2014, Infection, Genetics and EvolutionCitation Excerpt :Accordingly, this subtype was postulated to be a potential prognostic factor for more severe HCV-related liver disease. For example, Amoroso et al. (1998) provided data on the significantly higher rate of chronicity in infections caused by HCV subtype 1b (92% vs. 33–50% in the remaining genotypes) (Amoroso et al., 1998). There were, however, certain shortcomings of this study that might have distorted these results, such as a predominant occurrence of genotype 1 in the regions where the study was conducted and the use of assays that are more sensitive to genotype 1 than to the other genotypes.
Liver disease among renal transplant recipients
2013, Kidney Transplantation-Principles and Practice, Seventh EditionSingle-nucleotide polymorphism in the promoter region of the osteopontin gene at nucleotide -443 as a marker predicting the efficacy of pegylated interferon/ribavirin-therapy in Egyptians patients with chronic hepatitis C
2012, Human ImmunologyCitation Excerpt :The recently released Egyptian Demographic Health Survey [EDHS] tested a representative sample of the entire country for HCV antibody and revealed that the overall prevalence (percentage of people) positive for antibody to HCV was 14.7% [2]. The persistent viremia occurring due to HCV infection in 60–80% of such people [3,4] frequently produces chronic inflammation in the liver, hepatocyte necrosis due to cytotoxic T lymphocyte infiltration due to the T-helper (Th) 1 immune reaction, [5] and extracellular matrix (ECM) deposition in the space of Disse [6] and leads to gradual progression to liver fibrosis and cirrhosis 20–30 years after infection [7]. The incidence of hepatocellular carcinoma increased with the degree of hepatic fibrosis in patients with chronic hepatitis C and the annual incidence was 7.9% in patients with liver cirrhosis [8].